Astana Biomed Group, an authorized Abcam distributor in Central Asia

Neuroscience

cis-PPDA, GluN2C/GluN2D NMDA antagonist (ab120047)

Description:
GluN2C/GluN2D (formerly NR2C/NR2D) NMDA antagonist
Application:
Reactivity:
Conjugate:

Citalopram, 5-HT reuptake inhibitor (ab120133)

Description:
5-HT reuptake inhibitor
Application:
Reactivity:
Conjugate:

CPCCOEt, mGlu1 antagonist (ab120060)

Description:
Selective, non-competitive mGlu1 antagonist
Application:
Reactivity:
Conjugate:

D-Serine, endogenous NMDA receptor co-agonist (ab120048)

Description:
Endogenous NMDA receptor co-agonist
Application:
Reactivity:
Conjugate:

E-4031 dihydrochloride, HERG K+ channel blocker (ab120158)

Description:
HERG K+ channel blocker
Application:
Reactivity:
Conjugate:

Epothilone B, Microtubule stabilizing agent (ab141271)

Description:
Microtubule stabilizing agent
Application:
Reactivity:
Conjugate:

Erlotinib hydrochloride, EGFR tyrosine kinase inhibitor (ab141930)

Description:
Potent EGFR tyrosine kinase inhibitor
Application:
Reactivity:
Conjugate:

Evans blue, L-glutamate uptake inhibitor (ab120869)

Description:
Potent inhibitor of L-glutamate uptake
Application:
Reactivity:
Conjugate:

FFN511, Fluorescent substrate for VMAT2 (ab120331)

Description:
First novel fluorescent false neurotransmitter. Enables optical imaging of presynaptic terminal activity.
Application:
Reactivity:
Conjugate:

Flecainide, Sodium channel blocker (ab120504)

Description:
Sodium channel blocker
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.